Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.51 |
| ▸ | CCKAR | P32238 | 10/20 | 0.36 |
| ▸ | CCKBR | P32239 | 10/20 | 0.36 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15871467 | 1.00 | GLP1R (0.51) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16478807 | 0.97 | GLP1R (0.51) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16180954 | 0.93 | GLP1R (0.51) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16218298 | 0.93 | GLP1R (0.51) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16218301 | 0.93 | GLP1R (0.54) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16180974 | 0.93 | GLP1R (0.54) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16218077 | 0.93 | GLP1R (0.51) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16093394 | 0.92 | GLP1R (0.51) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16093409 | 0.92 | GLP1R (0.51) | GLP1RCCKARCCKBRNOD1 | |
| SCHEMBL16093469 | 0.87 | GLP1R (0.47) | GLP1RCCKARCCKBRNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8865868-B2 | Conjugated proteins with prolonged in vivo efficacy | NOVO NORDISK HEALTHCARE AG (CH) | 2014-10-21 | — | — | US | disclosed |
| US-8841249-B2 | Growth hormones with prolonged in-vivo efficacy | NOVO NORDISK A/S (DK) | 2014-09-23 | — | — | US | disclosed |